Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2003
10/23/2003US20030199009 Modifications of apoptin
10/23/2003US20030199005 Solid supports with minicells
10/23/2003US20030199002 For the treatment, management, or prevention of disorders associated with abnormal expression and/ or activity of clk-2 (clock-2) nucleic acids; treating or preventing disorders associated with decreased/increased apoptosis e.g. cancer
10/23/2003US20030198996 Production of achromosomal and anucleate cells useful for diagnositic and therapeutic uses, as well as research tools and agents for drug discovery
10/23/2003US20030198995 Production of achromosomal and anucleate cells useful for diagnostic and therapeutic uses, as well as research tools and agents for drug discovery
10/23/2003US20030198991 Nucleotide sequences coding for the ptsI protein
10/23/2003US20030198989 For use as a diagnostic reagent for detecting the presence or absence of a target molecule in a sample; Systematic Evolution of Ligands by EXponential enrichment (SELEX)
10/23/2003US20030198987 Methods for designing oligo-probes with high hybridization efficiency and high antisense activity
10/23/2003US20030198986 Differential screening of a rat hippocampus cDNA library; a cDNA species encoding a novel protein designated Hct-1 is shown to be related to cytochromes P450
10/23/2003US20030198982 Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
10/23/2003US20030198981 Genes and proteins involved in the biosynthesis of lipopeptides
10/23/2003US20030198980 Heteroconfigurational polynucleotides and methods of use
10/23/2003US20030198979 Method for detecting hybridized nucleic acid with improved sensitivity
10/23/2003US20030198975 Proteins associated with cell growth, differentiation, and death
10/23/2003US20030198974 Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library: application to the detection of mycobacteria
10/23/2003US20030198973 Catalyzing reaction between the reactive moiety of a protein intermediate and a coupling reagent on a modified nucleic acid to displace said moiety and form a covalent bond; peptide nucleic acids; probes and primers
10/23/2003US20030198970 Genostics
10/23/2003US20030198968 Coating a solid support via chemical plasma polymerization, and forming pendant functional group(s) for attaching a protein, nucleic acid or cell; polyacrylic acid with pendant acid groups converted to acyl fluorides for example
10/23/2003US20030198967 Multi-functional microarrays and methods
10/23/2003US20030198965 Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression
10/23/2003US20030198964 Nucleic acid separation and detection by electrophoresis with a counter-migrating high-affinity intercalating dye
10/23/2003US20030198959 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
10/23/2003US20030198956 Staged assembly of nanostructures
10/23/2003US20030198955 Novel proteins and nucleic acids encoding same
10/23/2003US20030198954 For forensic analyses, chromosome tissue/cell/organelle-specific markers, production of expression vectors, screening and diagnosis assays
10/23/2003US20030198953 For diagnosis, treatment, and prevention of related disorders
10/23/2003US20030198952 Probe bound substrate, process for manufacturing same, probe array, method of detecting target substance, method of specifying nucleotide sequence of single-stranded nucleic acid in sample, and quantitative determination of target substance in sample
10/23/2003US20030198950 For an oligonucleotide capable of predetermined biological function using selection of random nucleotide sequences
10/23/2003US20030198949 Viral polypeptides that regulate or modulate apoptosis
10/23/2003US20030198948 Synthetic nucleic acid double strands of optional sequence
10/23/2003US20030198947 Hepatitis virus sentinel virus I (SVI)
10/23/2003US20030198946 Hepatitis-C virus testing
10/23/2003US20030198944 Compositions and methods for reverse transcription of nucleic acid molecules
10/23/2003US20030198942 For imparting virus resistance to Vitis scion or rootstock cultivars
10/23/2003US20030198681 Method of making a protein polymer and uses of the polymer
10/23/2003US20030198678 Polynucleotide immobilized with block polyether polymer; antibodies against genetic disorders
10/23/2003US20030198664 Encapsulation drug; screening active materials
10/23/2003US20030198663 Phospholipid-analogous compounds
10/23/2003US20030198650 Equine herpes viruses; hybrid nucleic acid
10/23/2003US20030198647 Rheumatic diseases; autoimmune disease
10/23/2003US20030198635 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms
10/23/2003US20030198627 siRNA knockout assay method and constructs
10/23/2003US20030198626 Induction gene expression in cells of major histocompatibility complex; antitumor agents
10/23/2003US20030198625 Electroporation-mediated transfection of the salivary gland
10/23/2003US20030198624 Cytokine gene expression therapy; antiinflammatory agnets, respiratory system disorders
10/23/2003US20030198623 Attenuation Dna; coding cytokines, tumor antigen
10/23/2003US20030198621 Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof
10/23/2003US20030198620 Method of treating amino acid metabolic disorders using recombinant adeno-associated virus virions
10/23/2003US20030198596 Genetic engineered plasmids; diagnosis glandular disorders
10/23/2003US20030198575 Method and the device for micro-particle array fabrication
10/23/2003CA2849556A1 Preservation of bioactive materials by freeze dried foam
10/23/2003CA2521946A1 Method of identifying transmembrane protein-interacting compounds
10/23/2003CA2482926A1 Modified factor viii
10/23/2003CA2482904A1 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003CA2482903A1 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003CA2482841A1 Method of measuring human cyp3a inducibility
10/23/2003CA2482718A1 Derivatives of the il-2 receptor gamma chain, their production and use
10/23/2003CA2482634A1 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
10/23/2003CA2482438A1 Plant acyl-coa synthetases
10/23/2003CA2482395A1 Antiviral therapy on the basis of rna interference
10/23/2003CA2482387A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003CA2482244A1 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
10/23/2003CA2482126A1 Luminescent markers
10/23/2003CA2481905A1 Mutation detection and identification
10/23/2003CA2481895A1 Methods and reagents for assaying protein kinase activity
10/23/2003CA2481827A1 Polyvalent cation-sensing receptor in atlantic salmon
10/23/2003CA2481813A1 Antibody gene transfer and recombinant aav therefor
10/23/2003CA2481761A1 Methods for producing sulphurous fine chemicals by fermentation using meth-coding coryneform bacteria
10/23/2003CA2481747A1 Recombinant anti-interleukin-9 antibodies
10/23/2003CA2481509A1 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003CA2481508A1 G-protein coupled receptor ligands and methods
10/23/2003CA2481503A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
10/23/2003CA2481478A1 Stimulation of nerve cell regeneration
10/23/2003CA2481462A1 Heteroclitic analogs and related methods
10/23/2003CA2481372A1 Method to inhibit cell growth using oligonucleotides
10/23/2003CA2481358A1 Method for making a molecularly smooth surface
10/23/2003CA2481355A1 Hydrophobic zone device
10/23/2003CA2481339A1 Methods for targeting quadruplex dna
10/23/2003CA2481328A1 Monomeric and dimeric fluorescent protein variants and methods for making same
10/23/2003CA2481256A1 Embryo modification and implantation
10/23/2003CA2481244A1 Recombining viral vectors for the tetracycline-regulated expression of genes
10/23/2003CA2481186A1 Attenuated gram negative bacteria
10/23/2003CA2481087A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003CA2481074A1 Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors
10/23/2003CA2480990A1 Methods and devices for performing chemical reactions on a solid support
10/23/2003CA2480986A1 Process control based on microbiological activity
10/23/2003CA2480883A1 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
10/23/2003CA2480775A1 Immunostimulatory g,u-containing oligoribonucleotides
10/23/2003CA2480745A1 Methods for treating tweak-related conditions
10/23/2003CA2480454A1 Enhanced gene expression system
10/23/2003CA2480176A1 Use of interleukin-24 to treat ovarian cancer
10/23/2003CA2480079A1 Antiangiogenic active immunotherapy
10/23/2003CA2479996A1 Compositions for delivering enyzmes involved in acid metabolism using recombinant adeno-associated virus virons (raav virons), and method and use for treating amino acid metabolicdisorders using such raav virons
10/23/2003CA2479835A1 An ephrin-b receptor protein involved in carcinoma
10/23/2003CA2474486A1 Targeted chromosomal mutagenesis using zinc finger nucleases
10/22/2003EP1355157A1 FADD proteins, phosphorylated p38-MAPK and FasL as tumours markers
10/22/2003EP1355156A2 A human endothelin receptor
10/22/2003EP1355152A1 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen
10/22/2003EP1355151A2 Assessing colorectal cancer
10/22/2003EP1355150A2 Panel of nucleic acid sequences for cancer diagnosis
1 ... 2394 2395 2396 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 2408 2409 2410 2411 2412 2413 2414 ... 4023